NEW York, Nov. 16 – Lexicon Genetics has sublicensed aspects of its proprietary knockout mouse technology to Eli Lilly, the company announced Thursday.

The non-exclusive license covers the positive-negative selection and isogenic DNA technologies that Lexicon has licensed from academic researchers for its proprietary mouse gene function validation experiments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.